Publications by authors named "C V Caballero-Uribe"
The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis.
Rheumatology (Oxford)
September 2024
Article Synopsis
- The study investigates how comorbidities impact the quality of life in patients with idiopathic inflammatory myopathies (IIMs) compared to other autoimmune diseases and healthy individuals, utilizing self-reported data from the COVAD-2 survey.
- Results show IIM patients have significantly higher rates of comorbidities, basic multitasking, complex multitasking, and mental health disorders.
- The presence of these conditions correlates with lower overall physical and mental health scores, suggesting the need for targeted management strategies for IIM patients based on identified clinical clusters.
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.
Leonardo Palazzo Julius Lindblom Emelie Kihlgren Olsson Elena Nikiphorou Chris Wincup Carlo V Caballero-Uribe
Rheumatol Int
October 2024
Article Synopsis
- The study aimed to compare the occurrence of breakthrough COVID-19 infections (BIs) in fully vaccinated patients with systemic lupus erythematosus (SLE) against those with other rheumatic autoimmune diseases (rAIDs), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HCs).
- Results showed that 10.7% of SLE patients reported at least one BI, with frequencies similar to HCs and nrAID patients but higher than those with other rAIDs.
- Overall, vaccinated SLE patients experienced comparable levels of COVID-19 infection frequency and severity as healthy individuals, with no significant association found between demographic factors or treatments and BIs in SLE patients.
Article Synopsis
- A study explored the vaccine-related adverse events (AEs) and COVID-19 impacts among young adults (ages 18-35) with autoimmune diseases compared to healthy individuals, analyzing 20,685 responses from COVID-19 vaccination surveys.
- It found that early mild AEs were more common in patients with rheumatic (RMDs) and non-rheumatic autoimmune diseases (nr-ADs) compared to healthy controls, while severe AEs were rare across all groups.
- Despite the differences in infection and flare reports, the study confirmed the anti-SARS-CoV-2 vaccine's safety for young adults with autoimmune diseases, noting that disease type plays a bigger role in infection experiences than the use of immunosuppress